Abiraterone Acetate Versus Enzalutamide for Metastatic Castration-Resistant Prostate Cancer Post Chemotherapy- Cost Effectiveness Analysis
Nov 1, 2013, 00:00
10.1016/j.jval.2013.08.506
https://www.valueinhealthjournal.com/article/S1098-3015(13)02411-X/fulltext
Title :
Abiraterone Acetate Versus Enzalutamide for Metastatic Castration-Resistant Prostate Cancer Post Chemotherapy- Cost Effectiveness Analysis
Citation :
https://www.valueinhealthjournal.com/action/showCitFormats?pii=S1098-3015(13)02411-X&doi=10.1016/j.jval.2013.08.506
First page :
A411
Section Title :
Disease-Specific Studies
Open access? :
No
Section Order :
486